Norfluoxetine-d5
Norfluoxetine-d5 is the deuterated-labeled Norfluoxetine (HY-135556). Norfluoxetine is the active metabolite of the antidepressant Fluoxetine (HY-B0102); it is also a TREK-2 K2P potassium channel inhibitor with an IC50 of 2.7 μM. Norfluoxetine also inhibits placental aromatase (CYP19A1) (Ki = 2.1 µM), reduces placental estrogen secretion, and reduces serotonin transporter (SERT) activity. Norfluoxetine has neuroimmune activity, induces apoptosis in primary microglia (apoptosis), and inhibits the release of pro-inflammatory factors. Norfluoxetine inhibits neuronal high-threshold voltage-gated Ca2+ currents with an EC50 of 20.4 μM. Norfluoxetine can be used in research related to depression, ischemic stroke, and epilepsy.
For research use only. We do not sell to patients.
- CAS No.: 1185132-92-6
- Formula: C16H12D5ClF3NO
- Molecular Weight:336.79
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Calcium Channel Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
Aromatase 2.1 μM (Ki) |
Application
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
CAS No. 1185132-92-6
-
Unlabeled CAS 57226-68-3
-
Appearance Solid
-
Molecular Weight 336.79
-
Formula C16H12D5ClF3NO
-
Color White to off-white
-
SMILES
FC(F)(F)C(C=C1)=CC=C1OC(C2=CC=CC=C2)([2H])C([2H])([2H])C([2H])([2H])N.Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (273 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Proks P, et al. Norfluoxetine inhibits TREK-2 K2P channels by multiple mechanisms including state-independent effects on the selectivity filter gate. The Journal of general physiology. 2021 Aug 02;153(8):e202012812. [Content Brief]
[2]. Dhami KS, et al. Fluoxetine and its metabolite norfluoxetine induce microglial apoptosis. Journal of neurochemistry. 2019 Mar;148(6):761-778. [Content Brief]
[3]. Kecskeméti V, et al. Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies. Brain research bulletin. 2005 Sep 30;67(1-2):126-32. [Content Brief]
[4]. Hudon Thibeault AA, et al. Fluoxetine and its active metabolite norfluoxetine disrupt estrogen synthesis in a co-culture model of the feto-placental unit. Mol Cell Endocrinol. 2017 Feb 15;442:32-39. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Norfluoxetine-d5
- 1185132-92-6
- Isotope-Labeled Compounds
- Drug Metabolite
- Potassium Channel
- Calcium Channel
- Apoptosis
- Serotonin Transporter
- Cytochrome P450
- KcsA
- Ca2+ channels
- Ca channels
- 5-HTT
- SERT
- SLC6A4
- CYPs
- Xenopus laevis oocytes
- ischemic stroke
- voltage-gated Ca2+ channels
- rat cochlear neurons
- K2P10.1
- depression
- KCNK10
- TREK-2
- HEK293 cells
- primary rat microglia
- Inhibitor
- inhibitor
- inhibit